Race against time: experimental drug aims to extend lives in devastating heart disease
Disease control
Terminated
This study tested whether adding the experimental drug birtamimab to standard chemotherapy could help people with a severe, advanced stage of AL amyloidosis, a rare disease where abnormal proteins damage organs like the heart. It specifically enrolled 208 newly diagnosed patients…
Phase: PHASE3 • Sponsor: Prothena Biosciences Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC